Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 1/2015

01.01.2015 | Short Communication

Reduced retention of Pittsburgh compound B in white matter lesions

verfasst von: Lidia Glodzik, Henry Rusinek, Jinyu Li, Cyrus Zhou, Wai Tsui, Lisa Mosconi, Yi Li, Ricardo Osorio, Schantel Williams, Catherine Randall, Nicole Spector, Pauline McHugh, John Murray, Elizabeth Pirraglia, Shankar Vallabhajolusa, Mony de Leon

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

One of the interesting features of the amyloid tracer Pittsburgh compound B (PiB) is that it generates a signal in the white matter (WM) in both healthy subjects and cognitively impaired individuals. This characteristic gave rise to the possibility that PiB could be used to trace WM pathology. In a group of cognitively healthy elderly we examined PiB retention in normal-appearing WM (NAWM) and WM lesions (WML), one of the most common brain pathologies in aging.

Methods

We segmented WML and NAWM on fluid attenuation inversion recovery (FLAIR) images of 73 subjects (age 61.9 ± 10.0, 71 % women). PiB PET images were corrected for partial volume effects and coregistered to FLAIR images and WM masks. WML and NAWM PiB signals were then extracted.

Results

PiB retention in WML was lower than in NAWM (p < 0.001, 14.6 % reduction). This was true both for periventricular WML (p < 0.001, 17.8 % reduction) and deep WML (p = 0.001, 7.5 % reduction).

Conclusion

PiB binding in WM is influenced by the presence of WML, which lower the signal. Our findings add to the growing evidence that PiB can depict WM pathology and should prompt further investigations into PiB binding targets in WM.
Literatur
1.
Zurück zum Zitat Klunk WE, Engler H, Nordberg A, Yanming W, Blomqvist G, Holt DP, et al. Imaging brain amyloid in Alzheimer’s disease with Pittsburgh compound-B. Ann Neurol. 2004;55(3):306–19.PubMedCrossRef Klunk WE, Engler H, Nordberg A, Yanming W, Blomqvist G, Holt DP, et al. Imaging brain amyloid in Alzheimer’s disease with Pittsburgh compound-B. Ann Neurol. 2004;55(3):306–19.PubMedCrossRef
2.
Zurück zum Zitat Fodero-Tavoletti MT, Rowe CC, McLean CA, Leone L, Li Q-X, Masters CL, et al. Characterization of PiB binding to white matter in Alzheimer disease and other dementias. J Nucl Med. 2009;50:198–204.PubMedCrossRef Fodero-Tavoletti MT, Rowe CC, McLean CA, Leone L, Li Q-X, Masters CL, et al. Characterization of PiB binding to white matter in Alzheimer disease and other dementias. J Nucl Med. 2009;50:198–204.PubMedCrossRef
3.
Zurück zum Zitat Rowe CC, Ng S, Ackermann U, Gong SJ, Pike K, Savage G, et al. Imaging β-amyloid burden in aging and dementia. Neurology. 2007;68(20):1718–25.PubMedCrossRef Rowe CC, Ng S, Ackermann U, Gong SJ, Pike K, Savage G, et al. Imaging β-amyloid burden in aging and dementia. Neurology. 2007;68(20):1718–25.PubMedCrossRef
4.
Zurück zum Zitat Stankoff B, Freeman L, Aigrot MS, Chardain A, Dolle F, Williams A, et al. Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl-11C]-2-(4'-methylaminophenyl)- 6-hydroxybenzothiazole. Ann Neurol. 2011;69(4):673–80.PubMedCrossRef Stankoff B, Freeman L, Aigrot MS, Chardain A, Dolle F, Williams A, et al. Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl-11C]-2-(4'-methylaminophenyl)- 6-hydroxybenzothiazole. Ann Neurol. 2011;69(4):673–80.PubMedCrossRef
5.
Zurück zum Zitat Faria D de P, Copray S, Sijbesma JW, Willemsen AT, Buchpiguel CA, Dierckx RA, et al. PET imaging of focal demyelination and remyelination in a rat model of multiple sclerosis: comparison of [11C]MeDAS, [11C]CIC and [11C]PIB. Eur J Nucl Med Mol Imaging. 2014;41:995–1003. Faria D de P, Copray S, Sijbesma JW, Willemsen AT, Buchpiguel CA, Dierckx RA, et al. PET imaging of focal demyelination and remyelination in a rat model of multiple sclerosis: comparison of [11C]MeDAS, [11C]CIC and [11C]PIB. Eur J Nucl Med Mol Imaging. 2014;41:995–1003.
6.
Zurück zum Zitat Gouw AA, Seewann A, van der Flier WM, Barkhof F, Rozemuller AM, Scheltens P, et al. Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry. 2011;82:126–35.PubMedCrossRef Gouw AA, Seewann A, van der Flier WM, Barkhof F, Rozemuller AM, Scheltens P, et al. Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry. 2011;82:126–35.PubMedCrossRef
7.
Zurück zum Zitat Bech P, Kastrup M, Rafaelsen OJ. Mini-compendium of rating scales for states of anxiety depression mania schizophrenia with corresponding DSM-III syndromes. Acta Psychiatr Scand Suppl. 1986;326:1–37.PubMed Bech P, Kastrup M, Rafaelsen OJ. Mini-compendium of rating scales for states of anxiety depression mania schizophrenia with corresponding DSM-III syndromes. Acta Psychiatr Scand Suppl. 1986;326:1–37.PubMed
8.
Zurück zum Zitat Mikheev A, Nevsky G, Yitta S, Grosmann R, Rusinek H. Fully automated segmentation of the brain from T1-weighted MRI using bridge burner algorithm. J Magn Reson Imaging. 2008;27(6):1235–41.PubMedCrossRef Mikheev A, Nevsky G, Yitta S, Grosmann R, Rusinek H. Fully automated segmentation of the brain from T1-weighted MRI using bridge burner algorithm. J Magn Reson Imaging. 2008;27(6):1235–41.PubMedCrossRef
9.
Zurück zum Zitat Rusinek H, Glodzik L, Mikheev A, Zanotti A, Li Y, de Leon M. Fully automatic segmentation of white matter lesions: error analysis and validation of a new tool. Int J CARS. 2013;8 Suppl 1:289–91. Rusinek H, Glodzik L, Mikheev A, Zanotti A, Li Y, de Leon M. Fully automatic segmentation of white matter lesions: error analysis and validation of a new tool. Int J CARS. 2013;8 Suppl 1:289–91.
10.
Zurück zum Zitat Sachdev P, Chen X, Wen W. White matter hyperintensities in mid-adult life. Curr Opin Psychiatry. 2008;21:268–74.PubMedCrossRef Sachdev P, Chen X, Wen W. White matter hyperintensities in mid-adult life. Curr Opin Psychiatry. 2008;21:268–74.PubMedCrossRef
11.
Zurück zum Zitat Muller-Gartner HW, Links JM, Prince JL, Bryan RN, McVeigh E, Leal JP, et al. Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects. J Cereb Blood Flow Metab. 1992;12:571–83.PubMedCrossRef Muller-Gartner HW, Links JM, Prince JL, Bryan RN, McVeigh E, Leal JP, et al. Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects. J Cereb Blood Flow Metab. 1992;12:571–83.PubMedCrossRef
12.
Zurück zum Zitat Grimmer T, Faust M, Auer F, Alexopoulos P, Forstl H, Henriksen G, et al. White matter hyperintensities predict amyloid increase in Alzheimer’s disease. Neurobiol Aging. 2012;33:2766–73.PubMedCrossRef Grimmer T, Faust M, Auer F, Alexopoulos P, Forstl H, Henriksen G, et al. White matter hyperintensities predict amyloid increase in Alzheimer’s disease. Neurobiol Aging. 2012;33:2766–73.PubMedCrossRef
14.
Zurück zum Zitat Noh Y, Seo SW, Jeon S, Lee JM, Kim JH, Kim GH, et al. White matter hyperintensities are associated with amyloid burden in APOE4 non-carriers. J Alzheimers Dis. 2014;40(4):877–86.PubMed Noh Y, Seo SW, Jeon S, Lee JM, Kim JH, Kim GH, et al. White matter hyperintensities are associated with amyloid burden in APOE4 non-carriers. J Alzheimers Dis. 2014;40(4):877–86.PubMed
15.
Zurück zum Zitat Harauz G, Ishiyama N, Hill CM, Bates IR, Libich DS, Fares C. Myelin basic protein-diverse conformational states of an intrinsically unstructured protein and its roles in myelin assembly and multiple sclerosis. Micron. 2004;35(7):503–42.PubMedCrossRef Harauz G, Ishiyama N, Hill CM, Bates IR, Libich DS, Fares C. Myelin basic protein-diverse conformational states of an intrinsically unstructured protein and its roles in myelin assembly and multiple sclerosis. Micron. 2004;35(7):503–42.PubMedCrossRef
16.
Zurück zum Zitat Murray ME, Vemuri P, Preboske GM, Murphy MC, Schweitzer KJ, Parisi JE, et al. A quantitative postmortem MRI design sensitive to white matter hyperintensity differences and their relationship with underlying pathology. J Neuropathol Exp Neurol. 2012;71:1113–22.PubMedCentralPubMedCrossRef Murray ME, Vemuri P, Preboske GM, Murphy MC, Schweitzer KJ, Parisi JE, et al. A quantitative postmortem MRI design sensitive to white matter hyperintensity differences and their relationship with underlying pathology. J Neuropathol Exp Neurol. 2012;71:1113–22.PubMedCentralPubMedCrossRef
17.
Zurück zum Zitat Hong YT, Veenith T, Dewar D, Outtrim JG, Mani V, Williams C, et al. Amyloid imaging with carbon 11C-labeled Pittsburgh compound B for traumatic brain injury. JAMA Neurol. 2014;71(1):23–31.PubMedCentralPubMedCrossRef Hong YT, Veenith T, Dewar D, Outtrim JG, Mani V, Williams C, et al. Amyloid imaging with carbon 11C-labeled Pittsburgh compound B for traumatic brain injury. JAMA Neurol. 2014;71(1):23–31.PubMedCentralPubMedCrossRef
Metadaten
Titel
Reduced retention of Pittsburgh compound B in white matter lesions
verfasst von
Lidia Glodzik
Henry Rusinek
Jinyu Li
Cyrus Zhou
Wai Tsui
Lisa Mosconi
Yi Li
Ricardo Osorio
Schantel Williams
Catherine Randall
Nicole Spector
Pauline McHugh
John Murray
Elizabeth Pirraglia
Shankar Vallabhajolusa
Mony de Leon
Publikationsdatum
01.01.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 1/2015
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-014-2897-1

Weitere Artikel der Ausgabe 1/2015

European Journal of Nuclear Medicine and Molecular Imaging 1/2015 Zur Ausgabe